Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Guidelines search

Search Guidelines

  • Perinatal HIV Clinical Guidelines (40)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (37)
  • HIV Clinical Guidelines: Pediatric ARV (34)
  • (-) HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (13)
  • (-) HIV Clinical Guidelines: Pediatric Opportunistic Infections (6)
  • Guidance for Caring for People With HIV Displaced by Disasters (2)
Search Results 1 – 19 of 19
What's New in the Guidelines
… isolated anti–hepatitis B core antibody to reflect that tenofovir-sparing regimens can also be considered with …
Candida Infections
… but itraconazole may increase exposures and AEs from tenofovir disoproxil fumarate and tenofovir alafenamide. Most integrase strand transferase …
COVID-19
… of HIV (e.g., lopinavir/‌ritonavir, boosted darunavir, or tenofovir disoproxil fumarate/emtricitabine) have efficacy …
Hepatitis B Virus Infection
… HBV is recommended; the preferred regimen should include tenofovir (tenofovir disoproxil fumarate [TDF] or tenofovir alafenamide [TAF]) and either lamivudine (3TC) or …
Cytomegalovirus Disease
… other potentially nephrotoxic medications, including tenofovir disoproxil fumarate. Periodic ophthalmologic …
Hepatitis B Virus Infection
… routine HBV DNA testing is not recommended. However, if a tenofovir-sparing HIV regimen is being considered, some … people with HIV/HBV coinfection (median age 41 years) on tenofovir-containing antiretroviral therapy (ART), the … yearly (AIII). Special Considerations When Initiating Tenofovir-Sparing ARV Regimens In people without a history …
Hepatitis C Virus Infection
… the following: Velpatasvir can increase concentrations of tenofovir disoproxil fumarate and lead to tenofovir-related renal toxicity. It is unclear at this time whether this is also the case with tenofovir alafenamide. Nevertheless, care should be taken in …
Herpes Simplex Virus
… . Abdool Karim SS, Abdool Karim Q, Kharsany AB, et al. Tenofovir gel for the prevention of herpes simplex virus …
Hepatitis C Virus
… DAA regimens. Additionally, the improved safety profile of tenofovir alafenamide (TAF) combined with safety data in the … HBV = hepatitis B virus; HCV = hepatitis C virus; TDF = tenofovir disoproxil fumarate A limited pre-treatment … also increase velpatasvir exposure, which in turn increases tenofovir plasma exposure particularly when administered as …
Herpes Simplex Virus
… In clinical trials, pre-exposure prophylaxis with vaginal tenofovir gel and oral tenofovir disoproxil fumarate (TDF) or with … Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the …
Immunizations for Preventable Diseases in Adults and Adolescents With HIV
… ongoing risk factors for acquiring HBV and is not receiving tenofovir (CIII). 31 Waning immunity is typically seen in … Therapy Considerations HBV-active ART (includes tenofovir with lamivudine [3TC] or emtricitabine [FTC]) … incident HBV was similar in those taking lamivudine- or tenofovir-containing ART regimens. In another report of …
Mpox
… other potentially nephrotoxic medications, including tenofovir disoproxil fumarate. 97 Periodic (e.g., weekly) …
Disseminated Mycobacterium avium Complex Disease
… of TB suggests that bictegravir (coformulated   with tenofovir alafenamide and emtricitabine) might be used with … MP, et al. Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV …
Mycobacterium tuberculosis Infection and Disease
… = raltegravir; RTV = ritonavir; T-20 = enfuvirtide; TAF = tenofovir alafenamide; TB = tuberculosis Treatment of LTBI … = ritonavir; SC = subcutaneous; T-20 = enfuvirtide; TAF = tenofovir alafenamide; TB = tuberculosis; TDM = Therapeutic … reverse transcriptase inhibitors, including tenofovir disoproxil fumarate (TDF), tenofovir alafenamide …
Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections
… Sofosbuvir Bedaquiline Doxycycline Linezolid Rifabutin Tenofovir Chloroquine Fluconazole Mefloquine Rifampin … Rifampin. Rifapentine a See Rifapentine. See Rifapentine. Tenofovir Alafenamide Glecaprevir/Pibrentasvir See … See Sofosbuvir/Velpatasvir. See Sofosbuvir/Velpatasvir. Tenofovir Disoproxil Fumarate Rifabutin a See Rifabutin. See …
Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections
… Infusion- or injection-related reactions Thrombocytopenia Tenofovir Disoproxil Fumarate Renal insufficiency and … Decrease in bone mineral density Nausea and vomiting Tenofovir Alafenamide Lower incidence of renal or bone toxicities than with tenofovir disoproxil fumarate Trimethoprim-Sulfamethoxazole …
Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections that Require Dosage Adjustment in Adults With Renal Insufficiency
… Levofloxacin Posaconazole Pyrazinamide Quinine Rifabutin Tenofovir Trimethoprim Valacyclovir Voriconazole         … necessary. No dose adjustment necessary. Emtricitabine/ Tenofovir Alafenamide (FTC/TAF) (FDC Trade Name: Descovy) … on dialysis days, administer dose after HD. Emtricitabine/ Tenofovir Disoproxil Fumarate (FTC/TDF) (FDC Trade Name: …
Appendix A: List of Abbreviations
… SMX sulfamethoxazole TCA trichloroacetic acid TDF tenofovir disoproxil fumarate TMP trimethoprim TMP-SMX …
Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections
… valacyclovir, valganciclovir, ganciclovir, cidofovir ARVs: tenofovir Immunosuppressive agents : mycophenolate Monitor … or ototoxic drugs Antimycobacterials : capreomycin ARVs: tenofovir Antivirals : cidofovir Caution advised. Avoid … : aminoglycosides Antivirals : foscarnet ARVs : tenofovir Nephrotoxic drugs Monitor for toxicities of these …

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.